Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial
暂无分享,去创建一个
Ali Ahmed | Wilbert S Aronow | J. Fleg | M. Rich | M. Gheorghiade | W. Aronow | D. Kitzman | K. Adams | M. Zile | James B. Young | T. Love | James B Young | Dalane W Kitzman | Jerome L Fleg | Michael R Zile | Mihai Gheorghiade | Thomas E Love | Michael W Rich | Kirkwood F Adams | A. Ahmed
[1] F. Epstein,et al. Functional significance of Na- K-ATPase in the kidney: effects of ouabain inhibition. , 1972, The American journal of physiology.
[2] Douglas W Mahoney,et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.
[3] B. Massie,et al. Heart failure in patients with preserved left ventricular systolic function: do digitalis glycosides have a role? , 1998, Progress in cardiovascular diseases.
[4] D. Levy,et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. , 1999, Journal of the American College of Cardiology.
[5] D. Ferguson,et al. Digoxin. A neurohormonal modulator in heart failure? , 1991, Circulation.
[6] C. Warnes,et al. The adult with congenital heart disease: born to be bad? , 2005, Journal of the American College of Cardiology.
[7] J. Gardin,et al. Outcome of Congestive Heart Failure in Elderly Persons: Influence of Left Ventricular Systolic Function: The Cardiovascular Health Study , 2002, Annals of Internal Medicine.
[8] D. Ferguson,et al. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. , 1989, Circulation.
[9] K. Swedberg,et al. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. , 2004, Journal of the American College of Cardiology.
[10] P. Wolf,et al. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.
[11] A. Castellanos,et al. Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation. , 2005, Heart rhythm.
[12] D. M. Barr,et al. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. , 1996, Controlled clinical trials.
[13] R. Allman,et al. Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure. , 2002, American heart journal.
[14] R. Cody,et al. Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure. , 1983, The American journal of medicine.
[15] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.
[16] J. Carroll,et al. Heart Failure With a Normal Ejection Fraction: Is Measurement of Diastolic Function Necessary to Make the Diagnosis of Diastolic Heart Failure? , 2001, Circulation.
[17] E. Topol,et al. Hypertensive hypertrophic cardiomyopathy of the elderly. , 1985, The New England journal of medicine.
[18] J. Collins,et al. Determination of vital status at the end of the DIG trial. , 2003, Controlled clinical trials.
[19] M. Rich,et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. , 2006, European heart journal.
[20] D. Brutsaert,et al. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. , 2002, Circulation.
[21] E. J. Brown,et al. The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.
[22] A. Ahmed. Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failure. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[23] W. Hundley,et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. , 2002, JAMA.
[24] M. Gheorghiade,et al. Digoxin in the management of cardiovascular disorders. , 2004, Circulation.
[25] H N Sabbah,et al. Pressure‐Diameter Relations during Early Diastole in Dogs: Incompatibility with the Concept of Passive Left Ventricular Filling , 1981, Circulation research.
[26] W. Gaasch,et al. Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. , 2004, The New England journal of medicine.
[27] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .